Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$9.24 USD
+0.33 (3.70%)
Updated May 27, 2022 04:00 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/02/2022
Time: -- |
6/2022 | $-0.01 | -246.66% |
Earnings Summary
For their last quarter, Theravance Biopharma (TBPH) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of -$0.12 per share. This reflects a negative earnings surprise of 100.00%. Look out for TBPH's next earnings release expected on August 02, 2022. For the next earning release, we expect the company to report earnings of -$0.01 per share, reflecting a year-over-year increase of 98.75%.
Earnings History
Price & Consensus
Zacks News for TBPH
Theravance Biopharma (TBPH) Reports Q1 Loss, Lags Revenue Estimates
TBPH: What are Zacks experts saying now?
Zacks Private Portfolio Services